期刊文献+

加味三香汤治疗脾虚痰湿型功能性腹胀的临床观察 被引量:11

Clinical observation of Modifi ed San Xiang Decoction on functional bloating patients with spleen defi ciency and phlegm dampness
原文传递
导出
摘要 目的:观察中药加味三香汤治疗脾虚痰湿型功能性腹胀(FB)的临床疗效。方法:本研究采用随机、对照方法研究。笔者收集56例患者,随机分为治疗组与对照组。治疗组给予中药加味三香汤治疗,对照组给予西药桐木缘酸莫沙必利分散片治疗,疗程21d。结果:21d有效率治疗组显著高于对照组(85.7%与57.1%,P<0.05);治疗后两组症状积分均较治疗前显著较少(P<0.05),治疗组与对照组比较有显著性差异(P<0.05);腹围减少程度治疗组与对照组比较无显著性差异。安全性评价两组均无严重不良反应。结论:加味三香汤治疗脾虚痰湿型功能性腹胀具有良好的疗效及安全性。 Objective: To explore the influence of Modified San Xiang Decoction treatment on functional bloating patients with spleen deficiency and sputum dampness stagnancy. Methods: A randomized, contrast study was conducted. 56 cases functional bloating patients with spleen deficiency and sputum dampness were recruited and divided randomly into 2 groups, including treatment group and control group. Treatment group was administered Modified San Xiang Decoction, and control group was given Mosapride Citrate Tablets. The time is 21 days. Results: The effective rate in treatment was higher than control group after 21 days treatment (85.7% vs 57.1%, P〈0.05); Symptom score reduced significantly compared with before treatment in both groups (P〈0.05), and there was statistical difference between two groups (P〈0.05); No significant difference existed in abdominal girth reduction degree between two groups. Safety evaluation showed no serious adverse reaction happening in both groups. Conclusion: Modified San Xiang Decoction on functional bloating patients with spleen deficiency and sputum dampness stagnancy type is effective, and the adverse effect is very fewer.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2014年第3期930-932,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家中医药管理局十二五重点专科建设项目 中日友好医院院级课题(No.2013MS04)~~
关键词 加味三香汤 功能性腹胀 临床观察 Modified San Xiang Decoction Functional bloating Clinical study
  • 相关文献

参考文献12

二级参考文献15

  • 1邵池,赵宏,柯美云,王智凤.水负荷试验联合B超在评价功能性消化不良近端胃功能障碍中的地位[J].中华消化杂志,2005,25(1):23-26. 被引量:32
  • 2朱良如,谢小平,侯晓华.功能性消化不良患者胃机械感觉过敏[J].胃肠病学,2006,11(1):30-33. 被引量:11
  • 3SFDA.中药新药临床研究指导原则.北京:中国医药科技出版社.2002:390-391. 被引量:66
  • 4Talley N J, Boyce P, Jones M.Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population[J]. Gut, 1998,42 (5) : 690. 被引量:1
  • 5Douglas A. Drossman. The functional gastrointestinal disorders and the Rome III Process[J]. Gastroenterology, 2006,130(5) : 1 377. 被引量:1
  • 6Jan S, Ingemar S, Gerhard D. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease [J]. Digestive Diseasesand Sciences, 1988,33 ( 2 ) : 129. 被引量:1
  • 7Jiang X, Locke GR 3rd, Choung RS, et al. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study[J]. Gut, 2008,57 (6) : 756. 被引量:1
  • 8柯美云,方秀才主译.罗马Ⅲ-功能性胃肠病[M].第3版.北京:科学出版社,2008:452-456. 被引量:1
  • 9Hemando-Harder AC, Serra J, Azpiroz F, et al. Colonic responses to gas loads in subgroups of patients with abdominal bloating[J]. Am J Gastroenterol, 2010, 105 (4) : 876. 被引量:1
  • 10Grassini M, Battaglia E, Vema C, et al. Improvement of functional bloating by an enterovaccine: a preliminary study[J]. Rev Esp Enferm Dig, 2009, 101 (9) :619. 被引量:1

共引文献89

同被引文献147

引证文献11

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部